Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer

Completed · Phase 3

Conditions studied: Prostate Cancer

In brief

The primary purpose of this study is to evaluate two treatment regimens for prostate cancer, prostate implant with 20 Gy of external beam radiation therapy versus prostate implant with 0 Gy of external beam radiation therapy. Patients diagnosed with intermediate risk prostate cancer between the ages of 40 and 80 who have chosen brachytherapy with or without external beam radiation therapy as their intended treatment will be eligible and will be offered participation.

Key facts

Study ID

NCT00241384

Run by

Schiffler Cancer Center

People needed

396

Starts

2005-01-01

Expected to finish

2015-11-01

Last updated by the study team

2015-11-17

Who can join

Age: 40 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Patients with previously untreated prostatic cancer.
• Must have PSA 10-20 ng/ml, Gleason 7 to 9

You may not qualify if…

• Patients with proven regional lymph node involvement will be excluded.

Where it is running

• Veterans Administration Puget Sound Health Care System — Seattle, Washington, United States
• Schiffler Cancer Center — Wheeling, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.